HAEMORRHAGIC OVARIAN CYST

This adverse event was reported 575 times

These drugs are most commonly taken by patients reporting HAEMORRHAGIC OVARIAN CYST:

# Drug Count
0 LEVONORGESTREL 105
1 COPPER 48
2 ADALIMUMAB 39
3 RIVAROXABAN 28
4 INTERFERON BETA-1A 23
5 WARFARIN 21
6 ASPIRIN 16
7 ASPIRIN 325 MG 16
8 ASPIRIN 81 MG 16
9 FOLIC ACID 16
See all common drugs associated with HAEMORRHAGIC OVARIAN CYST

HAEMORRHAGIC OVARIAN CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Antihemophilic Factor [EPC] 2 0.0130
1 Human Blood Coagulation Factor [EPC] 2 0.0024
2 Sclerosing Agent [EPC] 1 0.0022
3 Gonadotropin [EPC] 4 0.0018
4 Serotonin-4 Receptor Agonist [EPC] 1 0.0015
5 CD33-directed Immunoconjugate [EPC] 4 0.0011
6 Copper-containing Intrauterine Device [EPC] 48 0.0010
7 Progestin [EPC] 120 0.0004
8 Anthelmintic [EPC] 1 0.0003
9 Vitamin D3 Analog [EPC] 5 0.0002
See all drug classes enriched for association with HAEMORRHAGIC OVARIAN CYST